Schizophrenia Market Research Reports

Schizophrenia Market Research

Schizophrenia is a severe, lifelong brain disorder. People who have it may hear voices, see things that aren’t there or believe that others are reading or controlling their minds.

Research indicates that the global schizophrenia market was worth $6.7bn in 2009. The global Schizophrenia therapeutics market is forecast to decline with a CAGR of (3.7%) to reach $5.1bn by 2017. This decline in the market is primarily attributed to the release of generics of some of the leading products during the period 2011-2014. The therapeutic market for schizophrenia is expected to decline form 2011 till mid 2014 due to the patent expiry of major marketed drugs such as Zyprexa, Abilify, Seroquel and Geodon. However in the late 2014, the situation is set to improve. There is a huge unmet need in the current market in terms of safety and efficacy. Furthermore, a low treatment seeking rate and low patient compliance rate are likely to act as a barrier to market growth.

The Schizophrenia drug therapy market research report provides insight into the pipeline status of schizophrenia therapeutics by company and by stage, as well as a summary of the latest news and developments in this area. In addition to new developments and disease specific pipeline projects, the listed reports also contain extensive information in tabular format on a company’s full product pipeline, and products by phase of development with regard to the therapy area. The study also helps in keeping track of the industry-specific competitors and partners by better understanding their product pipeline.

The study basically aims at providing a comprehensive overview of the on-goings of the schizophrenia drugs & therapy market.

 



 

View More
TITLE Actions
Global and United States Schizophrenia Therapeutics Market Report & Forecast 2022-2028
Published in Jun 2022 | US $ 4350 Onwards | By QYResearch Group

Schizophrenia Therapeutics market is segmented By Region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Schizophrenia Therapeutics market will be able to gain the upper hand as they u...

Global and United States Schizophrenia Drugs Market Report & Forecast 2022-2028
Published in Jun 2022 | US $ 4350 Onwards | By QYResearch Group

Schizophrenia Drugs market is segmented By Region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Schizophrenia Drugs market will be able to gain the upper hand as they use the report ...

Global and United States Schizophrenia Treatments Market Report & Forecast 2022-2028
Published in Jun 2022 | US $ 4350 Onwards | By QYResearch Group

Schizophrenia Treatments market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Schizophrenia Treatments market will be able to gain the upper hand as they use the rep...

2022-2029 Global Schizophrenia Therapeutic Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)
Published in May 2022 | US $ 2980 Onwards | By Maia Research

The Schizophrenia Therapeutic market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029. The report focuses on the Schizophrenia...

Global Schizophrenia Related Peptide Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
Published in May 2022 | US $ 3480 Onwards | By Global Info Research

The Schizophrenia Related Peptide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global...

Global Schizophrenia Related Peptide Market Research Report 2022
Published in May 2022 | US $ 2900 Onwards | By QYResearch Group

The research report includes specific segments by region (country), by company, by Purity and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the seg...

Cognitive Impairment Associated With Schizophrenia (CIAS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published in Mar 2022 | US $ 2000 Onwards | By Global Markets Direct

Cognitive Impairment Associated With Schizophrenia (CIAS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare dise...

Global Schizophrenia Therapeutic Market Research Report 2021 - Impact of COVID-19 on the Market
Published in Mar 2022 | US $ 3000 Onwards | By Maia Research

The Schizophrenia Therapeutic market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026. Considering the influence of COVID-19 on the gl...

Global Schizophrenia Drugs Market Insights and Forecast to 2028
Published in Mar 2022 | US $ 4900 Onwards | By QYResearch Group

Schizophrenia Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Schizophrenia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmenta...

Global Schizophrenia Therapeutics Market Insights and Forecast to 2028
Published in Feb 2022 | US $ 4900 Onwards | By QYResearch Group

Schizophrenia Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Schizophrenia Therapeutics market will be able to gain the upper hand as they use the...

Global Schizophrenia Treatments Market Insights, Forecast to 2028
Published in Feb 2022 | US $ 4900 Onwards | By QYResearch Group

Schizophrenia Treatments market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Schizophrenia Treatments market will be able to gain the upper hand as they use the rep...

Global Schizophrenia Treatments Market Growth (Status and Outlook) 2022-2028
Published in Jan 2022 | US $ 3660 Onwards | By LP Information INC

As the global economy mends, the 2021 growth of Schizophrenia Treatments will have significant change from previous year. According to our (LP Information) latest study, the global Schizophrenia Treatments market size is USD million in 2022 from USD...

Schizophrenia Drugs Market - Global Outlook and Forecast 2022-2028
Published in Jan 2022 | US $ 3250 Onwards | By Market Monitor Global

This report contains market size and forecasts of Schizophrenia Drugs in global, including the following market information: Global Schizophrenia Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions) Global Schizophrenia Drugs Market...

Schizophrenia Therapeutics Market - Global Outlook and Forecast 2022-2028
Published in Jan 2022 | US $ 3250 Onwards | By Market Monitor Global

Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition. This report contains market size and forecasts of...

Global Schizophrenia Drugs Market Research Report 2022 Professional Edition
Published in Jan 2022 | US $ 2890 Onwards | By HNY Research

The global Schizophrenia Drugs market was valued at 524.61 Million USD in 2021 and will grow with a CAGR of 2.43% from 2021 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on ...

Global Schizophrenia Drugs Market Research Report 2021 - Impact of COVID-19 on the Market
Published in Jan 2022 | US $ 3000 Onwards | By Maia Research

The Schizophrenia Drugs market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026. Considering the influence of COVID-19 on the global S...

Schizophrenia Drugs Market - Global Outlook and Forecast 2021-2027
Published in Dec 2021 | US $ 3250 Onwards | By Market Monitor Global

This report contains market size and forecasts of Schizophrenia Drugs in global, including the following market information: Global Schizophrenia Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions) Global Schizophrenia Drugs Market...

Schizophrenia Treatments Market - Global Outlook and Forecast 2021-2027
Published in Dec 2021 | US $ 3250 Onwards | By Market Monitor Global

This report contains market size and forecasts of Schizophrenia Treatments in Global, including the following market information: Global Schizophrenia Treatments Market Revenue, 2016-2021, 2022-2027, ($ millions) Global top five compani...

Global Schizophrenia Treatment Market Research Report 2021 - Impact of COVID-19 on the Market
Published in Dec 2021 | US $ 3000 Onwards | By Maia Research

The Schizophrenia Treatment market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026. Considering the influence of COVID-19 on the glob...

Schizophrenia Therapeutics Market - Global Outlook and Forecast 2021-2027
Published in Nov 2021 | US $ 3250 Onwards | By Market Monitor Global

This report contains market size and forecasts of Schizophrenia Therapeutics in Global, including the following market information: Global Schizophrenia Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions) Global top five com...

We are on:

Need Help?

Buy Any Report Avail 20% Discount. Coupon Code: DIS20

Connect for special KNOWLEDGE STORE Deals
Subscription starts at $ 20K